SYN Annual Non Current Assets
$1.51 M
+$1.03 M+216.60%
31 December 2021
Summary:
As of February 5, 2025, SYN annual long term assets is $1.51 million, with the most recent change of +$1.03 million (+216.60%) on December 31, 2021. During the last 3 years, it has risen by +$877.00 thousand (+139.21%).SYN Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYN Quarterly Non Current Assets
$27.44 M
-$2.00 M-6.80%
30 June 2022
Summary:
As of February 5, 2025, SYN quarterly long term assets is $27.44 million, with the most recent change of -$2.00 million (-6.80%) on June 30, 2022. Over the past year, it has increased by +$25.82 million (+1590.88%).SYN Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYN Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +216.6% | +1590.9% |
| 3 y3 years | +139.2% | +2674.8% |
| 5 y5 years | +68.4% | +3230.5% |
SYN Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -27.4% | -6.8% |
Synthetic Biologics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $27.44 M(-6.8%) |
| Mar 2022 | - | $29.45 M(+1853.9%) |
| Dec 2021 | $68.86 M(+767.9%) | $1.51 M(-3.6%) |
| Sept 2021 | - | $1.56 M(-3.6%) |
| June 2021 | - | $1.62 M(+288.3%) |
| Mar 2021 | - | $418.00 K(-12.2%) |
| Dec 2020 | $7.93 M(-51.7%) | $476.00 K(-12.0%) |
| Sept 2020 | - | $541.00 K(-13.6%) |
| June 2020 | - | $626.00 K(-12.8%) |
| Mar 2020 | - | $718.00 K(-11.2%) |
| Dec 2019 | $16.43 M(-44.3%) | $809.00 K(-10.0%) |
| Sept 2019 | - | $899.00 K(-9.1%) |
| June 2019 | - | $989.00 K(-8.3%) |
| Mar 2019 | - | $1.08 M(+71.1%) |
| Dec 2018 | $29.51 M(+64.5%) | $630.00 K(-8.4%) |
| Sept 2018 | - | $688.00 K(-8.8%) |
| June 2018 | - | $754.00 K(-8.5%) |
| Mar 2018 | - | $824.00 K(-7.9%) |
| Dec 2017 | $17.94 M(-16.8%) | $895.00 K(-7.3%) |
| Sept 2017 | - | $966.00 K(+17.2%) |
| June 2017 | - | $824.00 K(-6.6%) |
| Mar 2017 | - | $882.00 K(-5.0%) |
| Dec 2016 | $21.57 M(-28.9%) | $928.00 K(+52.6%) |
| Sept 2016 | - | $608.00 K(+19.7%) |
| June 2016 | - | $508.00 K(-3.6%) |
| Mar 2016 | - | $527.00 K(+3.7%) |
| Dec 2015 | $30.34 M(+59.1%) | $508.00 K(+2.2%) |
| Sept 2015 | - | $497.00 K(+297.6%) |
| June 2015 | - | $125.00 K(+34.4%) |
| Mar 2015 | - | $93.00 K(+31.0%) |
| Dec 2014 | $19.07 M(+17.6%) | $71.00 K(-2.7%) |
| Sept 2014 | - | $73.00 K(+28.1%) |
| June 2014 | - | $57.00 K(+29.5%) |
| Mar 2014 | - | $44.00 K(+7.3%) |
| Dec 2013 | $16.22 M(+30.1%) | $41.00 K(-74.5%) |
| Sept 2013 | - | $161.00 K(-5.3%) |
| June 2013 | - | $170.00 K(-26.1%) |
| Mar 2013 | - | $230.00 K(-76.0%) |
| Dec 2012 | $12.46 M(+75.0%) | $960.00 K(-1.6%) |
| Sept 2012 | - | $976.00 K(+0.2%) |
| June 2012 | - | $974.00 K(-4.9%) |
| Mar 2012 | - | $1.02 M(+189.3%) |
| Dec 2011 | $7.12 M(+100.9%) | $354.00 K(-39.2%) |
| Sept 2011 | - | $582.00 K(-5.3%) |
| June 2011 | - | $614.70 K(-1.1%) |
| Mar 2011 | - | $621.50 K(+9.8%) |
| Dec 2010 | $3.54 M(+28.7%) | $566.00 K(-42.2%) |
| Sept 2010 | - | $979.00 K(-9.8%) |
| June 2010 | - | $1.09 M(-9.6%) |
| Mar 2010 | - | $1.20 M(-9.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | $2.75 M(-53.5%) | $1.32 M(-6.8%) |
| Sept 2009 | - | $1.42 M(+16.3%) |
| June 2009 | - | $1.22 M(-9.0%) |
| Mar 2009 | - | $1.34 M(-8.2%) |
| Dec 2008 | $5.93 M(-48.7%) | $1.46 M(-14.8%) |
| Sept 2008 | - | $1.71 M(-9.6%) |
| June 2008 | - | $1.89 M(-5.2%) |
| Mar 2008 | - | $2.00 M(-3.9%) |
| Dec 2007 | $11.56 M(-5.4%) | $2.08 M(+6.5%) |
| Sept 2007 | - | $1.95 M(+25.1%) |
| June 2007 | - | $1.56 M(+149.1%) |
| Mar 2007 | - | $625.30 K(+110.3%) |
| Dec 2006 | $12.22 M(+955.3%) | $297.30 K(-55.6%) |
| Dec 2005 | $1.16 M(+38.6%) | - |
| Mar 2003 | - | $669.90 K(-1.4%) |
| Dec 2002 | $835.30 K(-39.2%) | $679.30 K(-6.5%) |
| Sept 2002 | - | $726.80 K(+0.0%) |
| June 2002 | - | $726.60 K(+7.1%) |
| Mar 2002 | - | $678.60 K(-0.7%) |
| Dec 2001 | $1.37 M(-72.0%) | $683.40 K(+13.1%) |
| Sept 2001 | - | $604.30 K(-6.2%) |
| June 2001 | - | $644.00 K(+22.7%) |
| Mar 2001 | - | $524.70 K(-3.0%) |
| Dec 2000 | $4.91 M(+8.2%) | $541.00 K(+1.6%) |
| Sept 2000 | - | $532.60 K(+11.8%) |
| June 2000 | - | $476.40 K(-8.2%) |
| Mar 2000 | - | $518.70 K(+1.8%) |
| Dec 1999 | $4.54 M(+74.6%) | $509.60 K(+69.9%) |
| Sept 1999 | - | $300.00 K(+50.0%) |
| June 1999 | - | $200.00 K(0.0%) |
| Mar 1999 | - | $200.00 K(-23.8%) |
| Dec 1998 | $2.60 M(+420.0%) | $262.50 K(+31.3%) |
| Sept 1998 | - | $200.00 K(+100.0%) |
| June 1998 | - | $100.00 K(0.0%) |
| Mar 1998 | - | $100.00 K(-50.0%) |
| Dec 1997 | $500.00 K(-80.0%) | $200.00 K(0.0%) |
| Sept 1997 | - | $200.00 K(-33.3%) |
| June 1997 | - | $300.00 K(+50.0%) |
| Mar 1997 | - | $200.00 K(-33.3%) |
| Dec 1996 | $2.50 M(+25.0%) | $300.00 K(0.0%) |
| Sept 1996 | - | $300.00 K(-40.0%) |
| June 1996 | - | $500.00 K(+25.0%) |
| Mar 1996 | - | $400.00 K(+100.0%) |
| Dec 1995 | $2.00 M(+1900.0%) | $200.00 K(+100.0%) |
| Sept 1995 | - | $100.00 K(-66.7%) |
| Dec 1994 | $100.00 K(-94.1%) | $300.00 K(+200.0%) |
| Mar 1994 | - | $100.00 K(0.0%) |
| Dec 1993 | $1.70 M | $100.00 K(>+9900.0%) |
| Sept 1993 | - | $0.00(0.0%) |
| June 1993 | - | $0.00(0.0%) |
| Mar 1993 | - | $0.00 |
FAQ
- What is Synthetic Biologics annual long term assets?
- What is the all time high annual non current assets for Synthetic Biologics?
- What is Synthetic Biologics annual non current assets year-on-year change?
- What is Synthetic Biologics quarterly long term assets?
- What is the all time high quarterly non current assets for Synthetic Biologics?
- What is Synthetic Biologics quarterly non current assets year-on-year change?
What is Synthetic Biologics annual long term assets?
The current annual non current assets of SYN is $1.51 M
What is the all time high annual non current assets for Synthetic Biologics?
Synthetic Biologics all-time high annual long term assets is $2.08 M
What is Synthetic Biologics annual non current assets year-on-year change?
Over the past year, SYN annual long term assets has changed by +$1.03 M (+216.60%)
What is Synthetic Biologics quarterly long term assets?
The current quarterly non current assets of SYN is $27.44 M
What is the all time high quarterly non current assets for Synthetic Biologics?
Synthetic Biologics all-time high quarterly long term assets is $29.45 M
What is Synthetic Biologics quarterly non current assets year-on-year change?
Over the past year, SYN quarterly long term assets has changed by +$25.82 M (+1590.88%)